JONAH LAHIP: Open Payments
NPI 1396289518 · BAKERSFIELD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$508 in 23 payments from 9 companies in 2025. Trend: 2023 $721 · 2024 $343 · 2025 $508
Food & beverage: $508
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 5 | $123 |
| Amgen Inc. | 4 | $77 |
| Novartis Pharmaceuticals Corporation | 3 | $75 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $67 |
| HEARTFLOW, INC. | 2 | $44 |
| Actelion Pharmaceuticals US, Inc. | 2 | $43 |
| Alnylam Pharmaceuticals Inc. | 2 | $40 |
| PFIZER INC. | 1 | $26 |
| E.R. Squibb & Sons, L.L.C. | 1 | $14 |
Products named: VERQUVO, Repatha, LEQVIO, JARDIANCE, FFRct, UPTRAVI, AMVUTTRA, ELIQUIS.
Industry payments across CA — which companies pay providers there.
